Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Anesthesiology. 2011 May;114(5):1190–1199. doi: 10.1097/ALN.0b013e318212515b

Figure 5.

Figure 5

In vitro effects of pharmacologic disruption with capsazepine (CPZ), an agonist of the transient receptor potential vanilloid-1 on wild-type splenocytes challenged with lipopolysaccharide for 16 h on tumor necrosis factor alpha (panel A), macrophage inflammatory protein (panel B), and interleukin-10 (panel C) gene expression. Relative expressions (y-axis) for each gene were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and are relative to the gene expression in vehicle-treated WT splenocytes challenged with phosphate buffered saline (PBS). Results are shown as means±SEM of three separate experiments and each of these three experiments was performed by pooling the spleens of 2 animals in each of the groups studied. Log relative expressions and p values indicate comparison between groups indicated by brackets.